Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 4,342 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Time Management Clear all

Conditions: Sickle Cell Disease, Pain, Acupuncture, Quantitative Sensory Testing, Magnetic Resonance Imaging, Circulating Biomarkers, Electroencephalography, Functional Near-infrared Spectroscopy
Interventions: needling acupuncture, laser acupuncture; Device
Lead sponsor: Indiana University; Other
Eligibility: 14 Years to 80 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Tobacco Use Disorder, Homelessness
Interventions: Nicotine Patches, mobile contingency management (mCM), Smoking cessation counseling, Nicotine rescue method, Bupropion; Drug · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetes, End Stage Renal Disease
Interventions: EchoMark/EchoSure, Standard of Care; Device · Procedure
Lead sponsor: Sonavex, Inc.; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 23
States / cities: Dothan, Alabama • Phoenix, Arizona • Tucson, Arizona + 19 more

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Counseling, Health Education, Interview, Medical Chart Review, Monitoring, Questionnaire Administration; Other · Behavioral
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 486 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2033
U.S. locations: 30
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Albany, Georgia + 21 more

Conditions: Developmental Dysplasia of the Hip
Interventions: Intraoperative contrast-enhanced ultrasound (CEUS), Lumason; Diagnostic Test · Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Months to 24 Months
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer, Ovarian Cancer
Interventions: E39 peptide vaccine, E39 vaccine then J65 vaccine, J65 vaccine then E39 vaccine; Biological
Lead sponsor: COL George Peoples, MD, FACS; Federal
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cholecystitis, Acute
Interventions: Not listed
Lead sponsor: European Society for Trauma and Emergency Surgery; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Back Pain
Interventions: Treatment with BTL-043, BTL-899; Device
Lead sponsor: BTL Industries Ltd.; Industry
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Scottsdale, Arizona • Fort Myers, Florida • Columbus, Ohio + 1 more

Conditions: Neuroendocrine Tumors
Interventions: 18F-MFBG (meta-fluoro benzylguanidine), Positron emission tomography (PET) imaging, Blood draws; Radiation · Device · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 5 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer
Interventions: Patient Navigator (PN), Baseline Questionnaire, Follow-up Questionnaire, Patient Navigator Satisfaction Survey; Behavioral · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years to 39 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Insufficient Sleep, Obesity
Interventions: Fixed sleep goal, Personalized sleep goal, Digital sleep health messaging without virtual study visit, Digital sleep health messaging with virtual study visit, Inactive Parent-Directed Loss-Framed Incentive, Active Parent-Directed Loss-Framed Incentive, Inactive Supportive Feedback, Active Supportive Feedback; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 12 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gastrointestinal Cancer, Neuroendocrine Carcinoma, Skin Cancer
Interventions: Aromatherapy and Essential Oils, Subject Diary; Procedure · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Hyperlipidemia, Hypertension, Obesity
Interventions: Nutritional counseling, Walking program, Simple pedometer, Enhanced pedometer; Behavioral · Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obesity
Interventions: Whey Protein supplement, Soy Protein Supplement, Carbohydrate supplement; Dietary Supplement
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 30 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Lanthanum carbonate, placebo, Ascorbic Acid, Nitroglycerin, Flow-mediated dilation measurement, Aortic pulse-wave velocity, Endothelial cell collection; Drug · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 79 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes Mellitus
Interventions: Glucose to Goal, Usual Care; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4,994 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Malignant Head and Neck Neoplasm, Mucositis, Radiation-Induced Disorder
Interventions: Educational Intervention, Gabapentin, Pain Therapy, Quality-of-Life Assessment, Questionnaire Administration, Oxycodone/Acetaminophen, Hydrocodone/Acetaminophen, Fentanyl, Ibuprofen, Magic Mouthwash; Other · Drug
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Breast Cancer
Interventions: Group Sessions; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 21 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 2
States / cities: Miami, Florida

Conditions: Alzheimer Disease
Interventions: Cognitive Assessment; Other
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 65 Years and older
Enrollment: 1,423 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Pain, Postoperative, Cesarean Section Complications, Postpartum Disorder, Opioid Use
Interventions: Oxycodone Acetaminophen; Other
Lead sponsor: ProMedica Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Metastatic Colorectal Cancer
Interventions: Regorafenib (Stivarga, BAY73-4506); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 2,326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Multiple Locations, New Jersey

Conditions: Diabetes Complications, Peripheral Arterial Disease
Interventions: Exercise, Walking Program, Health Self-Management Support; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 85 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Body Fat Disorder
Interventions: The Zeltiq System; Device
Lead sponsor: Zeltiq Aesthetics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Parkinson Disease, Dysarthria
Interventions: Remote speech rehabilitation; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 25 Years to 85 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Search by objective public record fields.

Integrative Medicine in Pain Management in Sickle Cell Disease

Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH

Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients

SnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis

Safety and Efficacy of the BTL-043 and BTL-899 Devices in Alleviating Back Pain

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Veterans Walk for Health Study

Whey Protein, Resistance Training, and Changes in Body Composition

Phosphate Lowering in CKD Trial

Glucose to Goal: A Model to Support Diabetes Management in Primary Care

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Facilitating Adjustment in Low Income Black Women With Breast Cancer

Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease

Satisfaction Following Cesarean Section

An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

Collaborative-care Rehabilitation After Dysvascular Amputation

Pilot Study on the Submental Area

Dysarthria Management for Minor Groups